Revenue ($USD) : $457,433,000
R&D spend : $26,162,000
Employees : 2,600
Fiscal year end : 12/31/2023
CEO : Vafa Jamali

www.zimvie.com

At the end of 2023, ZimVie — created from the spine and dental units that spun out from Zimmer Biomet — announced that it planned to sell its spine and bone healing businesses to H.I.G. Capital, establishing it as a pure-play dental company. (Those businesses made their debut on this year's Medtech Big 100 as Highridge Medical.) About six months after closing the deal, ZimVie sale rumors started, with suggestions that South Korea–based dental implant maker Osstem was bidding for the company. –SW